​
​

Ovid Therapeutics (OVID) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Ovid Therapeutics Revenue Highlights

Latest Revenue (Y)

$391.69M

Latest Revenue (Q)

$173.00K

Main Segment (Y)

License

Ovid Therapeutics Revenue by Period

Ovid Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$391.69M25965.25%
2022-12-31$1.50M-99.28%
2021-12-31$208.38M1551.57%
2020-12-31$12.62M100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31--

Ovid Therapeutics generated $391.69M in revenue during NA 2023, up 25965.25% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Ovid Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30$173.00K2.37%
2024-06-30$169.00K14.19%
2024-03-31$148.00K4.55%
2023-12-31$141.56K29.91%
2023-09-30$108.97K45.30%
2023-06-30$75.00K13.36%
2023-03-31$66.16K42.96%
2022-12-31$46.28K316.86%
2022-09-30$11.10K100.00%
2022-06-30--100.00%
2022-03-31$1.45M-100.35%
2021-12-31$-416.35M100.00%
2021-09-30-100.00%
2021-06-30--100.00%
2021-03-31$208.38M3553.80%
2020-12-31$5.70M-17.51%
2020-09-30$6.91M100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31--

Ovid Therapeutics generated $173.00K in revenue during Q3 2024, up 2.37% compared to the previous quarter, and up 230.67% compared to the same period a year ago.

Ovid Therapeutics Revenue Breakdown

Ovid Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22Dec 21
Related Party-$196.00M
License$1.50M$12.38M

Ovid Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 22: License (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 22Mar 22Mar 21
Related Party--$196.00M
License$11.10K$1.45M$12.38M

Ovid Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 22: License (100.00%).

Ovid Therapeutics Revenue Breakdown by Country

Quarterly Revenue by Country

CountrySep 22Mar 22Mar 21
License$11.10K$1.45M$12.38M
Related Party--$196.00M

Ovid Therapeutics's latest quarterly revenue breakdown by geography, as of Sep 22: License (100.00%).

Ovid Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
OVIDOvid Therapeutics$391.69M$173.00K
CTMXCytomX Therapeutics$101.21M$33.43M
SPROSpero Therapeutics$96.73M$13.47M
ASMBAssembly Biosciences$7.16M$6.84M
CNTBConnect Biopharma--
NXTCNextCure--
TILInstil Bio--
NLTXNeurogene--
ACHLAchilles Therapeutics--
NUVBNuvation Bio-$727.00K

OVID Revenue FAQ

What is Ovid Therapeutics’s yearly revenue?

Ovid Therapeutics's yearly revenue for 2023 was $391.7M, representing an increase of 25965.25% compared to 2022. The company's yearly revenue for 2022 was $1.5M, representing a decrease of -99.28% compared to 2021. OVID's yearly revenue for 2021 was $208.38M, representing an increase of 1551.57% compared to 2020.

What is Ovid Therapeutics’s quarterly revenue?

Ovid Therapeutics's quarterly revenue for Q3 2024 was $173K, a 2.37% increase from the previous quarter (Q2 2024), and a 58.76% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $169K, a 14.19% increase from the previous quarter (Q1 2024), and a 125.33% increase year-over-year (Q2 2023). OVID's quarterly revenue for Q1 2024 was $148K, a 4.55% increase from the previous quarter (Q4 2023), and a 123.70% increase year-over-year (Q1 2023).

What is Ovid Therapeutics’s revenue growth rate?

Ovid Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 87.97%, and for the last 5 years (2019-2023) was 0%.

What are Ovid Therapeutics’s revenue streams?

Ovid Therapeutics's revenue streams in c 22 are License

What is Ovid Therapeutics’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of Ovid Therapeutics was License. This segment made a revenue of $1.5M, representing 100.00% of the company's total revenue.